Detalles de la búsqueda
1.
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience.
Oncologist
; 28(11): e1065-e1074, 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37156009
2.
The cultural politics of mining and natural disaster in Indonesia: by fire and sword.
Disasters
; 41(1): 23-40, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26988726
3.
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets.
JTO Clin Res Rep
; 5(2): 100623, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38357092
4.
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival.
JCO Precis Oncol
; 7: e2200540, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36716413
5.
ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC.
Clin Cancer Res
; 29(23): 4958-4972, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37733794
6.
Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC.
JTO Clin Res Rep
; 4(8): 100533, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37649681
7.
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.
Nat Commun
; 14(1): 695, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36755027
8.
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
Lancet Digit Health
; 5(7): e404-e420, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37268451
9.
Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung Cancer.
Clin Lung Cancer
; 23(3): 236-243, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35216923
10.
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab.
JAMA Netw Open
; 5(6): e2215589, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35666500
11.
Induction chemotherapy with or without erlotinib in patients with head and neck squamous cell carcinoma amenable for surgical resection.
Clin Cancer Res
; 2022 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35443062
12.
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.
Nat Commun
; 13(1): 1797, 2022 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35379845
13.
STK11/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition.
Clin Cancer Res
; 27(6): 1720-1733, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33323404
14.
Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations.
Chest
; 159(3): 1256-1264, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33217413
15.
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC.
J Thorac Oncol
; 16(4): 601-609, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33388476
16.
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC.
J Thorac Oncol
; 15(9): 1449-1459, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32389639
17.
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma.
Clin Cancer Res
; 26(4): 892-901, 2020 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31694833
18.
Vaccine-Induced Protection Against Furunculosis Involves Pre-emptive Priming of Humoral Immunity in Arctic Charr.
Front Immunol
; 10: 120, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30778356
19.
Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable Alterations.
Clin Lung Cancer
; 20(1): 30-36.e3, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30279110
20.
PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung Cancer.
J Thorac Oncol
; 14(6): 1021-1031, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30780001